(MedPage Today) — At the recent American Society of Hematology annual meeting, investigators presented a new analysis detailing toxicity outcomes of the E1910 trial — based on age, sex, body mass index, cytogenetic-molecular risk, and cycles…
Source link : https://www.medpagetoday.com/meetingcoverage/ashvideopearlsall/119295
Author :
Publish date : 2026-01-06 17:15:00
Copyright for syndicated content belongs to the linked Source.
